TIMASHEVA, Y.R.,
NASIBULLIN, T.R.,
MUSTAFINA, O.E.,
BALKHIYAROVA, Z.R.,
PROKOPENKO, I.,
AVZALETDINOVA, D.S.,
MORUGOVA, T.V. (2019) of European ancestry and therefore the
disease risk estimations can be inaccurate when extrapolated to other
Zaplakhova, O. V.,
Nasibullin, T. R.,
Tuktarova, I. A.,
Timasheva, Y. R.,
Erdman, V. V.,
Bakhtiyarova, K. Z.,
Mustafina, O. E. (2018) Multiple sclerosis (MS) is regarded as multifactorial, polygenic
disease; its development
Isaeva, A.,
Averyanov, S.,
Iskhakov, I.,
Gulyaeva, O.,
Gileva, O.,
Kiniabaev, T. (2020) High prevalence of inflammatory periodontal
diseases in young people along with unfavourable
GORDEEVA, A.V.,
SITDIKOVA, I.D.,
GALIMOVA, I.A.,
GUREVSKAYA, O.А.,
USMANOVA, I.N.,
DETOCHKINA, V.R. (2019) of remission of the
disease, and reducing the rate of relapses and the severity of clinical manifestations
treating a
disease, but this must be viewed as inconsistent in medical history. The beginnings of radical
Karasev, S.M.,
Sufianov, A.A.,
Khafizov, R.R.,
Karaseva, I.I.,
Shugushev, Z.K.,
Maximkin, D.A.,
Khafizov, T.N. (2021) common pathology, which remains one of the most diagnostically and therapeutically complex
diseases diseases. In fact, several studies have documented the induction of corneal endothelial-like cells (CECs
Yang, L.,
Luo, W.,
Zhang, Q,
Hong, S.,
Wang, Y.,
Samorodov, A.V.,
Chattipakorn, N.,
Pavlov, V.N.,
Liang, G. (2021) potent anti-inflammatory efficacy in several
disease models, which could be the potential candidates
Guan, XX,
Zhang, YW,
Gareev, I,
Beylerli, O,
Li, XY,
Lu, GT,
Lv, L,
Hai, X (2021) treatment of the
disease. This study aimed to test our hypothesis that a miR-499a played an important role